Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Bloomberg Markets

Novo-Backed Drugmaker Avalyn Soars 44% After $300 Million US IPO

Novo-Backed Drugmaker Avalyn Soars 44% After $300 Million US IPO
ShareXFacebook

Avalyn Pharma Inc. shares jumped 44% in its trading debut, after the biopharmaceutical company raised $300 million in an upsized US initial public offering.

B

Source

Bloomberg Markets

Read full article at Bloomberg Markets

Opens original article in a new tab

Advertisement

Related Economy Stories

Iran’s New Leader Pledges to Guard Nuclear and Missile Tech
Bloomberg Markets

Iran’s New Leader Pledges to Guard Nuclear and Missile Tech

Iran’s new supreme leader gave a rare statement on Thursday, vowing not to give up the country’s nuclear or missile technologies and signaling Tehran would keep control of the Strait of Hormuz. Natasha Hall, Associate Fellow at Chatham House joins to discuss on Balance of Power. (Source: Bloomberg)

Read more →
Advertisement